Joe Verghese1, Emmeline Ayers2, Nir Barzilai2, David A Bennett2, Aron S Buchman2, Roee Holtzer2, Mindy J Katz2, Richard B Lipton2, Cuiling Wang2. 1. From the Departments of Neurology (J.V., E.A., R.H., M.J.K., R.B.L.), Medicine (J.V., N.B.), and Epidemiology and Population Health (R.B.L., C.W.), Albert Einstein College of Medicine, Bronx, NY; Rush Alzheimer's Disease Center (D.A.B., A.S.B.), Rush University Medical Center, Chicago, IL; and Ferkauf School of Psychology (R.H.), Yeshiva University, Bronx, NY. joe.verghese@einstein.yu.edu. 2. From the Departments of Neurology (J.V., E.A., R.H., M.J.K., R.B.L.), Medicine (J.V., N.B.), and Epidemiology and Population Health (R.B.L., C.W.), Albert Einstein College of Medicine, Bronx, NY; Rush Alzheimer's Disease Center (D.A.B., A.S.B.), Rush University Medical Center, Chicago, IL; and Ferkauf School of Psychology (R.H.), Yeshiva University, Bronx, NY.
Abstract
OBJECTIVE: To report incidence and risk factors for motoric cognitive risk syndrome (MCR), a newly described predementia syndrome characterized by slow gait and cognitive complaints. METHODS: We examined incidence rates of MCR in 3,128 adults aged 60 years and older, MCR- and dementia-free at baseline, participating in 4 US-based cohort studies. Hazard ratios (HRs) with 95% confidence intervals (CIs) for the association of modifiable risk factors with risk of MCR were computed using Cox models. RESULTS: Over a median follow-up time of 3.2 years, 823 of the 3,128 participants met MCR criteria. The overall age- and sex-adjusted incidence of MCR was 65.2/1,000 person-years (95% CI: 53.3-77.1), and ranged from 50.8/1,000 person-years to 79.6/1,000 person-years in the individual cohorts. MCR incidence was higher with older age but there were no sex differences. In the pooled sample adjusted for age, sex, education, and cohort source, strokes (HR 1.42, 95% CI: 1.14-1.77), Parkinson disease (HR 2.52, 95% CI: 1.68-3.76), depressive symptoms (HR 1.65, 95% CI: 1.28-2.13), sedentariness (HR 1.76, 95% CI: 1.44-2.17), and obesity (HR 1.39, 95% CI: 1.17-1.65) predicted risk of incident MCR. CONCLUSIONS: The incidence of MCR is high in older adults. Identification of modifiable risk factors for MCR will improve identification of high-risk individuals and help develop interventions to prevent cognitive decline in aging.
OBJECTIVE: To report incidence and risk factors for motoric cognitive risk syndrome (MCR), a newly described predementia syndrome characterized by slow gait and cognitive complaints. METHODS: We examined incidence rates of MCR in 3,128 adults aged 60 years and older, MCR- and dementia-free at baseline, participating in 4 US-based cohort studies. Hazard ratios (HRs) with 95% confidence intervals (CIs) for the association of modifiable risk factors with risk of MCR were computed using Cox models. RESULTS: Over a median follow-up time of 3.2 years, 823 of the 3,128 participants met MCR criteria. The overall age- and sex-adjusted incidence of MCR was 65.2/1,000 person-years (95% CI: 53.3-77.1), and ranged from 50.8/1,000 person-years to 79.6/1,000 person-years in the individual cohorts. MCR incidence was higher with older age but there were no sex differences. In the pooled sample adjusted for age, sex, education, and cohort source, strokes (HR 1.42, 95% CI: 1.14-1.77), Parkinson disease (HR 2.52, 95% CI: 1.68-3.76), depressive symptoms (HR 1.65, 95% CI: 1.28-2.13), sedentariness (HR 1.76, 95% CI: 1.44-2.17), and obesity (HR 1.39, 95% CI: 1.17-1.65) predicted risk of incident MCR. CONCLUSIONS: The incidence of MCR is high in older adults. Identification of modifiable risk factors for MCR will improve identification of high-risk individuals and help develop interventions to prevent cognitive decline in aging.
Authors: Sujuan Gao; Frederick W Unverzagt; Kathleen S Hall; Kathleen A Lane; Jill R Murrell; Ann M Hake; Valerie Smith-Gamble; Hugh C Hendrie Journal: Am J Geriatr Psychiatry Date: 2013-07-03 Impact factor: 4.105
Authors: David A Bennett; Steven E Arnold; Michael J Valenzuela; Carol Brayne; Julie A Schneider Journal: Acta Neuropathol Date: 2013-12-20 Impact factor: 17.088
Authors: Joe Verghese; Richard B Lipton; Charles B Hall; Gail Kuslansky; Mindy J Katz; Herman Buschke Journal: N Engl J Med Date: 2002-11-28 Impact factor: 91.245
Authors: Michelle M Mielke; Rosebud O Roberts; Rodolfo Savica; Ruth Cha; Dina I Drubach; Teresa Christianson; Vernon S Pankratz; Yonas E Geda; Mary M Machulda; Robert J Ivnik; David S Knopman; Bradley F Boeve; Walter A Rocca; Ronald C Petersen Journal: J Gerontol A Biol Sci Med Sci Date: 2012-12-18 Impact factor: 6.053
Authors: Nir Barzilai; Gil Atzmon; Clyde Schechter; Ernst J Schaefer; Adrienne L Cupples; Richard Lipton; Suzanne Cheng; Alan R Shuldiner Journal: JAMA Date: 2003-10-15 Impact factor: 56.272
Authors: Joe Verghese; Cedric Annweiler; Emmeline Ayers; Nir Barzilai; Olivier Beauchet; David A Bennett; Stephanie A Bridenbaugh; Aron S Buchman; Michele L Callisaya; Richard Camicioli; Benjamin Capistrant; Somnath Chatterji; Anne-Marie De Cock; Luigi Ferrucci; Nir Giladi; Jack M Guralnik; Jeffrey M Hausdorff; Roee Holtzer; Ki Woong Kim; Paul Kowal; Reto W Kressig; Jae-Young Lim; Susan Lord; Kenichi Meguro; Manuel Montero-Odasso; Susan W Muir-Hunter; Mohan L Noone; Lynn Rochester; Velandai Srikanth; Cuiling Wang Journal: Neurology Date: 2014-07-16 Impact factor: 9.910
Authors: Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng Journal: Lancet Date: 2004 Sep 11-17 Impact factor: 79.321
Authors: Nan Wang; Gilles Allali; Chandrasekharan Kesavadas; Mohan L Noone; Vayyattu G Pradeep; Helena M Blumen; Joe Verghese Journal: J Alzheimers Dis Date: 2016 Impact factor: 4.472
Authors: Neelesh K Nadkarni; Oscar L Lopez; Subashan Perera; Stephanie A Studenski; Beth E Snitz; Kirk I Erickson; Chester A Mathis; Robert D Nebes; Mark Redfern; William E Klunk Journal: J Gerontol A Biol Sci Med Sci Date: 2017-03-01 Impact factor: 6.053
Authors: Keith A Shaughnessy; Kyle J Hackney; Brian C Clark; William J Kraemer; Donna J Terbizan; Ryan R Bailey; Ryan McGrath Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Michele L Callisaya; Emmeline Ayers; Nir Barzilai; Luigi Ferrucci; Jack M Guralnik; Richard B Lipton; Petr Otahal; Velandai K Srikanth; Joe Verghese Journal: J Alzheimers Dis Date: 2016-06-18 Impact factor: 4.472